rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
1
|
pubmed:dateCreated |
1999-1-28
|
pubmed:abstractText |
An elevated plasma homocysteine level is an established risk factor for atherosclerotic coronary heart disease (CHD), cerebrovascular disease (CVD), and lower extremity occlusive disease (LED). An elevated plasma homocysteine level can be reduced by therapy with folate and vitamins B6 and B12. An accurate evaluation of the role of vitamin therapy requires knowledge of the influence of plasma homocysteine levels on the progression of CHD, CVD, and LED.
|
pubmed:grant |
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Jan
|
pubmed:issn |
0741-5214
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
29
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
8-19; discussion 19-21
|
pubmed:dateRevised |
2007-11-15
|
pubmed:meshHeading |
pubmed-meshheading:9925456-Aged,
pubmed-meshheading:9925456-Analysis of Variance,
pubmed-meshheading:9925456-Arteriosclerosis,
pubmed-meshheading:9925456-Cardiovascular Diseases,
pubmed-meshheading:9925456-Cerebrovascular Disorders,
pubmed-meshheading:9925456-Coronary Artery Disease,
pubmed-meshheading:9925456-Disease Progression,
pubmed-meshheading:9925456-Female,
pubmed-meshheading:9925456-Homocysteine,
pubmed-meshheading:9925456-Humans,
pubmed-meshheading:9925456-Hyperhomocysteinemia,
pubmed-meshheading:9925456-Male,
pubmed-meshheading:9925456-Middle Aged,
pubmed-meshheading:9925456-Mortality,
pubmed-meshheading:9925456-Multivariate Analysis,
pubmed-meshheading:9925456-Peripheral Vascular Diseases,
pubmed-meshheading:9925456-Prospective Studies,
pubmed-meshheading:9925456-Risk Factors,
pubmed-meshheading:9925456-Single-Blind Method
|
pubmed:year |
1999
|
pubmed:articleTitle |
Prospective blinded study of the relationship between plasma homocysteine and progression of symptomatic peripheral arterial disease.
|
pubmed:affiliation |
Division of Vascular Surgery, and the General Clinical Research Center,Oregon Health Sciences University, Portland 97201, USA.
|
pubmed:publicationType |
Journal Article,
Research Support, U.S. Gov't, P.H.S.
|